1. Home
  2. IBP vs CORT Comparison

IBP vs CORT Comparison

Compare IBP & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Installed Building Products Inc.

IBP

Installed Building Products Inc.

HOLD

Current Price

$224.63

Market Cap

8.2B

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$92.13

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBP
CORT
Founded
1977
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
9.7B
IPO Year
2014
2001

Fundamental Metrics

Financial Performance
Metric
IBP
CORT
Price
$224.63
$92.13
Analyst Decision
Hold
Buy
Analyst Count
8
5
Target Price
$266.14
$96.50
AVG Volume (30 Days)
425.9K
980.8K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
1.18%
N/A
EPS Growth
6.70
N/A
EPS
1.29
N/A
Revenue
$2,970,800,000.00
$761,407,000.00
Revenue This Year
$1.96
$26.08
Revenue Next Year
$4.32
$26.98
P/E Ratio
$176.95
N/A
Revenue Growth
1.00
12.79
52 Week Low
$182.88
$28.66
52 Week High
$349.00
$91.00

Technical Indicators

Market Signals
Indicator
IBP
CORT
Relative Strength Index (RSI) 51.60 81.77
Support Level $195.46 $76.41
Resistance Level $229.34 N/A
Average True Range (ATR) 9.05 3.76
MACD 2.63 -0.02
Stochastic Oscillator 61.27 94.76

Price Performance

Historical Comparison
IBP
CORT

About IBP Installed Building Products Inc.

Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: